Sujit Basu

7PUBLICATIONS
6CO-AUTHORS
Biologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGenetically modified horticulture plants
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 12, 2026
Dopamine D2 Receptor Agonists as Modulators of VEGF-A-Driven Angiogenesis: Mechanisms, Clinical Evidence, and Translational Opportunities.

|Jul 08, 2024
IL-27 Gene Therapy Ameliorates IPEX Syndrome Caused by Germline Mutation of Foxp3 Gene: A Major Role for Induction of IL-10.

Jin-Qing Liu, Ali Jabbari, Cho-Hao Lin

|Feb 10, 2024
Therapeutic Immunomodulation in Gastric Cancer.

Venu Akkanapally, Xue-Feng Bai, Sujit Basu

|May 20, 2022
VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells.

Chandrani Sarkar, Debanjan Chakroborty, Sandeep Goswami

|Nov 23, 2020
Chebulinic acid is a safe and effective antiangiogenic agent in collagen-induced arthritis in mice.

Kai Lu, O Hans Iwenofu, Rita Mitra

Pageof 2